Reagenzgläser
Vesalius Biocapital

A European life sciences venture capital investor

.

About us

Vesalius Biocapital is a European life sciences venture capital investor. The active fund Vesalius Biocapital III had a final closing in May 2019 with € 120 million in commitments.

We are investing in appealing, later-stage companies in drug development, medical devices & diagnostics and eHealth / mHealth, predominantly in Europe. Our portfolio companies address unmet medical & market needs and operate on the basis of strong intellectual property protection.

 

Fund 3

Vesalius Biocapital III

Vintage 2017 - € 120 million assets under management. In investment mode

read more

 

News

Vesalius News

OMEICOS Appoints Dr Simon Russell as CEO
read more
Tonic App raises 3.5 million euros
read more
Mecuris GmbH: Best MedTech Startup
read more
.

xxnoxx_zaehler